These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3627599)

  • 1. Fetal supraventricular tachycardia treated with high-dose quinidine: toxicity associated with marked elevation of the metabolite, 3(S)-3-hydroxyquinidine.
    Killeen AA; Bowers LD
    Obstet Gynecol; 1987 Sep; 70(3 Pt 2):445-9. PubMed ID: 3627599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific determination of quinidine and (3S)-3-hydroxyquinidine in human serum by high-pressure liquid chromatography.
    Drayer DE; Restivo K; Reidenberg MM
    J Lab Clin Med; 1977 Nov; 90(5):816-22. PubMed ID: 908870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fetal supraventricular tachycardia: in utero therapy with digoxin and quinidine.
    Spinnato JA; Shaver DC; Flinn GS; Sibai BM; Watson DL; Marin-Garcia J
    Obstet Gynecol; 1984 Nov; 64(5):730-5. PubMed ID: 6493666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of quinidine sulfate throughout pregnancy.
    Hill LM; Malkasian GD
    Obstet Gynecol; 1979 Sep; 54(3):366-8. PubMed ID: 471380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transplacental cardioversion of fetal supraventricular tachycardia using sotalol].
    Meden H; Neeb U
    Z Geburtshilfe Perinatol; 1990; 194(4):182-4. PubMed ID: 2396467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total and unbound concentrations of quinidine and 3-hydroxyquinidine at steady state.
    Wooding-Scott RA; Visco J; Slaughter RL
    Am Heart J; 1987 Feb; 113(2 Pt 1):302-6. PubMed ID: 3812182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fetal and maternal magnetocardiography during flecainide therapy for supraventricular tachycardia.
    Campbell JQ; Best TH; Eswaran H; Lowery CL
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):767-71. PubMed ID: 17018496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiarrhythmic activity of two quinidine metabolites in experimental reperfusion arrhythmia: relative potency and pharmacodynamic interaction with the parent drug.
    Vozeh S; Oti-Amoako K; Uematsu T; Follath F
    J Pharmacol Exp Ther; 1987 Oct; 243(1):297-301. PubMed ID: 3668860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma concentrations of quinidine, its major metabolites, and dihydroquinidine in patients with torsades de pointes.
    Thompson KA; Murray JJ; Blair IA; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1988 Jun; 43(6):636-42. PubMed ID: 3378385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence supporting 3(S)-3-hydroxyquinidine-associated cardiotoxicity.
    Bowers LD; Nelson KM; Connor R; Lais CJ; Krauss E
    Ther Drug Monit; 1985; 7(3):308-12. PubMed ID: 4049469
    [No Abstract]   [Full Text] [Related]  

  • 11. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R; Moulin MA; Charbonneau P; Bazin C
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrops from reciprocating atrioventricular tachycardia in a 27-week fetus requiring quinidine for conversion.
    Guntheroth WG; Cyr DR; Mack LA; Benedetti T; Lenke RR; Petty CN
    Obstet Gynecol; 1985 Sep; 66(3 Suppl):29S-33S. PubMed ID: 4022512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high-pressure liquid chromatography method for serum quinidine and (3S)-3-hydroxyquinidine.
    Weidner N; Ladenson JH; Larson L; Kessler G; McDonald JM
    Clin Chim Acta; 1979 Jan; 91(1):7-13. PubMed ID: 761394
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of 3-hydroxyquinidine in patients receiving initial intravenous quinidine gluconate for electrophysiology testing of ventricular tachycardia.
    Ackerman BH; Olsen KM; Kennedy EE; Taylor EH; Chen BH; Jordan D; Ackerman DJ
    DICP; 1989 May; 23(5):375-8. PubMed ID: 2728524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The therapeutic management of a twin pregnancy complicated by the presence of cervical cancer, following laparoscopic staging and chemotherapy, with an emphasis on cisplatin concentrations in the fetomaternal compartments amnion fluid, umbilical cord, and maternal serum.
    Marnitz S; Schmittel A; Bolbrinker J; Schmidt FP; Fons G; Kalache K; Schneider A; Köhler C
    Fertil Steril; 2009 Nov; 92(5):1748.e1-4. PubMed ID: 19765705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal supraventricular tachycardia treated with flecainide acetate.
    Perry JC; Ayres NA; Carpenter RJ
    J Pediatr; 1991 Feb; 118(2):303-5. PubMed ID: 1899700
    [No Abstract]   [Full Text] [Related]  

  • 17. [Fetal supraventricular tachycardia treated with transplacental digoxin].
    Devesa R; de Miguel JR; Cavero A; Montero JJ; Vallés P
    Rev Esp Cardiol; 1994 Feb; 47(2):116-8. PubMed ID: 8165347
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chronic renal insufficiency. Elevated levels of the active metabolite (3-hydroxyquinidine) of quinidine].
    Camsonne R; Moulin MA; Ryckelynck JP; Mignot P; Albessard F; Perault M; Bigot MC; Richard O
    Nouv Presse Med; 1982 Oct; 11(41):3062-3. PubMed ID: 7145692
    [No Abstract]   [Full Text] [Related]  

  • 19. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neonatal flecainide toxicity following supraventricular tachycardia treatment.
    Hall CM; Ward Platt MP
    Ann Pharmacother; 2003 Sep; 37(9):1343-4. PubMed ID: 12921523
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.